1
Total investments
0
Early stage
1
Mid stage
0
Late stage
5y
Years active
Portfolio
1 investments ยท sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Jun 2021
Spintly brings to you "SMART ACCESS"โ, a smart access control system which allows easy and secure entry to your modern workplace area. It allows you to unleash the power of your smartphone by converting it into a smart access card. Spintly-Smart Access is very easy to install, adopt and use.
Spintly uses a fully wireless back-end system eliminating the need for wired infrastructure.
Experience ยท 5 entries
All (5)
Investments (1)
Founder (1)
Board (1)
2023
Venture Partner & Advisor
Jun 2023
Investing in light asset companies worldwide to disrupt and decarbonize traditional markets: energy, mobility, buildings and industrials by digitization, electrification and Automation (AI).
2021
Board Member
Jun 2021
Spintly brings to you "SMART ACCESS"โ, a smart access control system which allows easy and secure entry to your modern workplace area. It allows you to unleash the power of your smartphone by converting it into a smart access card. Spintly-Smart Access is very easy to install, adopt and use.
Spintly uses a fully wireless back-end system eliminating the need for wired infrastructure.
2020
K
Strategic Advisor
Oct 2020
Kyto Technology and Life Science, Inc., formerly Kyto Biopharma, Inc., seeks to develop a specialized vehicle for early stage technology and life science companies. The Company operates as a mentor, advisor, external manager and investor for selected privately held companies in the United States of America, Canada and Israel. The Companys portfolio includes CNote Group, Inc. (CNote), Exodos/Achelios Therapeutics, Inc. (Achelios), Seal Rock Therapeutics, Inc., and Crater, LLC (Crater). CNote provides an alternative savings product that pays up to 35x the interest of a traditional savings account. Crater provides the SurveyBot software program, which enables video chat between a moving companys representative and the customer. Achelios is a specialty pharmaceutical company with primary focus on new therapeutic entity (NTE) development for the treatment of pain and inflammation by delivered medications.
1992
President, CEO & Founder
Jan 1992
Inventures provides professional management services to help guide, launch, and operate alliances and associations. For more than 25 years, weโve launched or provided management to more than 50 multi-stakeholder communities across a wide variety of industries. More information is available at www.inventures.com.
